Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 153 articles: HTML format

Single Articles

April 2021
1. ABDELLATIF M, Salama Y, Alhammali T, Eltweri AM, et al
   Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
   Br J Surg. 2021 Apr 1. pii: 6207608. doi: 10.1093.
   PubMed    
   
   
   March 2021
2. AGUIAR S, Riechelmann RP, de Mello CAL, da Silva JCF, et al
   Impact of COVID-19 on colorectal cancer presentation.
   Br J Surg. 2021;108:e81-e82.
   PubMed    
   
   
   January 2021
3. ABDULKARIM A, Barasa M
   Clinicopathological profile of colorectal cancer at a tertiary hospital in Kenya.
   Br J Surg. 2021 Jan 31. pii: 6124826. doi: 10.1093.
   PubMed    
   
   
   
4. HABIB BEDWANI N, English W, Coda S, Akinlade F, et al
   Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
   Br J Surg. 2021;108:e18-e19.
   PubMed    
   
   
   
5. CAHILL RA, O'Shea DF, Khan MF, Khokhar HA, et al
   Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification.
   Br J Surg. 2021;108:5-9.
   PubMed    
   
   
   
6. TOLLEY T, Whewell H, Davies DR, Codd RJ, et al
   Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing.
   Br J Surg. 2021 Jan 25. pii: 6120047. doi: 10.1093.
   PubMed    
   
   
   
7. YOKOYAMA S, Fujita Y, Matsumura S, Yoshimura T, et al
   Cribriform carcinoma in the lymph nodes is associated with distant metastasis, recurrence, and survival among patients with node-positive colorectal cancer.
   Br J Surg. 2021 Jan 11. pii: 6082763. doi: 10.1093.
   PubMed    
   
   
   December 2020
8. HEALEY BIRD BRJ
   Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
   Br J Surg. 2020;107:1705-1707.
   PubMed    
   
   
   
9. VAN OOSTENDORP SE, Smits LJH, Vroom Y, Detering R, et al
   Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
   Br J Surg. 2020;107:1719-1730.
   PubMed     Abstract available
   
   
   
10. DENOST Q, Solomon M, Tuech JJ, Ghouti L, et al
    International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
    Br J Surg. 2020;107:1846-1854.
    PubMed     Abstract available
    
    
    
11. LIGHTNER AL, Vaidya P, Vogler S, McMichael J, et al
    Surveillance pouchoscopy for dysplasia: Cleveland Clinic Ileoanal Pouch Anastomosis Database.
    Br J Surg. 2020;107:1826-1831.
    PubMed     Abstract available
    
    
    
12. JORGREN F, Lydrup ML, Buchwald P
    Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:1818-1825.
    PubMed     Abstract available
    
    
    November 2020
13. MARCHEGIANI F, Barina A, Spolverato G, Pucciarelli S, et al
    Defunctioning stoma in young patients affected by rectal cancer: a delicate balance.
    Br J Surg. 2020;107:e639.
    PubMed    
    
    
    
14. HIDAYAT H, Etherson K, Shanmugam V
    Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e627.
    PubMed    
    
    
    
15. PETROV A
    Author response to: Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e628.
    PubMed    
    
    
    
16. JORGREN F, Lydrup ML, Buchwald P
    Author response to: Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e622.
    PubMed    
    
    
    
17. WU Q, Jin Z, Peng Y, Wang Z, et al
    Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e621.
    PubMed    
    
    
    
18. TUYNMAN JB, van Oostendorp SE, Kusters M, Sietses C, et al
    Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e612.
    PubMed    
    
    
    
19. WASMUTH HH, Larsen SG, Faerden AE
    TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e611.
    PubMed    
    
    
    
20. PEACOCK O, Limvorapitak T, Hu CY, Bednarski BK, et al
    Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes.
    Br J Surg. 2020;107:1552-1557.
    PubMed     Abstract available
    
    
    
21. WILLIAMSON JS, Quyn AJ, Sagar PM
    Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management.
    Br J Surg. 2020;107:1562-1569.
    PubMed     Abstract available
    
    
    October 2020
22. HUDDY JR, Freeman Z, Crockett M, Hadjievangelou N, et al
    Establishing a "cold" elective unit for robotic colorectal and urological cancer surgery and regional vascular surgery following the initial COVID-19 surge.
    Br J Surg. 2020;107:e466-e467.
    PubMed    
    
    
    
23. 
    The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer.
    Br J Surg. 2020;107:e547-e548.
    PubMed    
    
    
    
24. ZHOU X, Liu Z, Zhang D, Wu L, et al
    Improving initial nodal staging of T3 rectal cancer using quantitative image features.
    Br J Surg. 2020;107:e541-e542.
    PubMed    
    
    
    
25. EFETOV SK, Lychagin AV, Zubayraeva AA, Picciariello A, et al
    3D-printed pubic bone for pelvic ring reconstruction after exenteration for anal cancer recurrence.
    Br J Surg. 2020;107:e512-e514.
    PubMed    
    
    
    September 2020
26. MA J, Whittaker Y, Chandran P
    Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer.
    Br J Surg. 2020 Sep 8. doi: 10.1002/bjs.12033.
    PubMed    
    
    
    
27. LIYANAGE ASD, Gokul K, Babu BH, Ainsworth P, et al
    Stage migration of colorectal cancer during COVID-19 pandemic.
    Br J Surg. 2020 Sep 2. doi: 10.1002/bjs.11936.
    PubMed    
    
    
    
28. BARRETT K, Habib Bedwani N, Arya S, Bhargava A, et al
    Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Br J Surg. 2020 Sep 1. doi: 10.1002/bjs.12008.
    PubMed    
    
    
    
29. DETERING R, van Oostendorp SE, Meyer VM, van Dieren S, et al
    MRI cT1-2 rectal cancer staging accuracy: a population-based study.
    Br J Surg. 2020;107:1372-1382.
    PubMed     Abstract available
    
    
    
30. SAKAMOTO T, Fujiogi M, Lefor AK, Matsui H, et al
    Stent as a bridge to surgery or immediate colectomy for malignant right colonic obstruction: propensity-scored, national database study.
    Br J Surg. 2020;107:1354-1362.
    PubMed     Abstract available
    
    
    August 2020
31. KONTOVOUNISIOS C
    The impact of the COVID-19 pandemic on colorectal cancer service provision.
    Br J Surg. 2020 Aug 28. doi: 10.1002/bjs.11990.
    PubMed    
    
    
    
32. BEHM KT, Grass F, Abd El Aziz MA, Kelley SR, et al
    Short term oncological outcomes of completely intracorporeal anastomosis after left sided robotic resections for colorectal cancer.
    Br J Surg. 2020 Aug 26. doi: 10.1002/bjs.11955.
    PubMed    
    
    
    
33. TREASURE T, Leonard P, Milosevic M, Williams NR, et al
    Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
    Br J Surg. 2020 Aug 21. doi: 10.1002/bjs.11948.
    PubMed    
    
    
    
34. DARVISH-DAMAVANDI M, Laycock J, Ward C, van Driel MS, et al
    An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
    Br J Surg. 2020 Aug 10. doi: 10.1002/bjs.11911.
    PubMed    
    
    
    
35. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Author response to: NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020;107:e358.
    PubMed    
    
    
    
36. MARINO F, Trompetto M, Gallo G
    COVID-19 pandemic: a large boulder on the head of stoma patients.
    Br J Surg. 2020;107:e303.
    PubMed    
    
    
    
37. WARRIER SK, Bell S, Guest G, Heriot A, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during the exploration phase.
    Br J Surg. 2020;107:e353.
    PubMed    
    
    
    
38. BERGAMASCHI R, Gachabayov M, Orangio G, Remzi F, et al
    Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e347.
    PubMed    
    
    
    
39. VAN OOSTENDORP SE, Sietses C, Hompes R, Kusters M, et al
    Author response to: Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e348.
    PubMed    
    
    
    
40. VAN OOSTENDORP SE, Belgers HJ, Bootsma BT, Hol JC, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.
    Br J Surg. 2020;107:1211-1220.
    PubMed     Abstract available
    
    
    July 2020
41. CARRANO FM, Foppa C, Carvello M, Spinelli A, et al
    With adequate precautions colorectal cancer surgery can be safely continued during COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11859.
    PubMed    
    
    
    
42. CHAN DKH, Keh CHL, Seow CS, Iau PTC, et al
    Maintaining quality of care in colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11866.
    PubMed    
    
    
    
43. MAEDA Y, Dunlop MG, Din FVN
    Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic.
    Br J Surg. 2020 Jul 23. doi: 10.1002/bjs.11798.
    PubMed    
    
    
    
44. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    PubMed    
    
    
    
45. MIRNEZAMI R, Knowles J, Kar A, Glynne-Jones R, et al
    Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic.
    Br J Surg. 2020;107:e263.
    PubMed    
    
    
    
46. GIANI I, Elbetti C, Trompetto M, Gallo G, et al
    Proctology in the COVID-19 era: handle with care.
    Br J Surg. 2020;107:e243.
    PubMed    
    
    
    
47. TSUKAMOTO S, Fujita S, Kanemitsu Y
    Author response to: Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e291.
    PubMed    
    
    
    
48. PEPARINI N
    Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e290.
    PubMed    
    
    
    
49. PEREA J, Garcia JL, Garcia-Olmo D, Urioste M, et al
    Comment on: Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:e277.
    PubMed    
    
    
    June 2020
50. TUTTON MG
    Colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11734.
    PubMed    
    
    
    
51. D'SOUZA N, Abulafi M
    Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    Br J Surg. 2020;107:e204.
    PubMed    
    
    
    
52. LACY AM, De Lacy FB, Balibrea JM
    Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Br J Surg. 2020;107:e203.
    PubMed    
    
    
    
53. WARRIER SK, Bell S, Kong JC, Larach T, et al
    Comments on: Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:e221.
    PubMed    
    
    
    
54. LARSEN SG, Faerden AE, Wasmuth HH
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e222.
    PubMed    
    
    
    
55. WASMUTH HH, Faerden AE, Larsen SG
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e224.
    PubMed    
    
    
    
56. SEOW-EN I, Seow-Choen F
    Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e223.
    PubMed    
    
    
    
57. CRIPPA J, Grass F, Larson DW
    Author response to: Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e227.
    PubMed    
    
    
    
58. YANG TH, Shen Y
    Comment on: Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:e225.
    PubMed    
    
    
    
59. JIA HD, Diao YK, Li C, Liang L, et al
    Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e226.
    PubMed    
    
    
    
60. SOCHA J, Bujko K
    Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e211-e212.
    PubMed    
    
    
    
61. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e213-e214.
    PubMed    
    
    
    May 2020
62. ALTAF K, Tan J, Parvaiz A, Ahmed S, et al
    Impact on colorectal cancer in COVID-19 pandemic.
    Br J Surg. 2020 May 29. doi: 10.1002/bjs.11720.
    PubMed    
    
    
    
63. 
    Colorectal cancer services during the COVID-19 pandemic.
    Br J Surg. 2020 May 22. doi: 10.1002/bjs.11706.
    PubMed    
    
    
    
64. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    PubMed    
    
    
    
65. DIAO YK, Liang L, Li C, Zhang CW, et al
    Is there a causal relationship between blood cultures after surgery for colorectal cancer and long-term oncological outcomes?
    Br J Surg. 2020;107:773.
    PubMed    
    
    
    April 2020
66. CULLINANE CM, Creavin B, O'Connell EP, Kelly L, et al
    Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
    Br J Surg. 2020 Apr 16. doi: 10.1002/bjs.11603.
    PubMed     Abstract available
    
    
    
67. KATAOKA K, Beppu N, Shiozawa M, Ikeda M, et al
    Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11517.
    PubMed     Abstract available
    
    
    
68. DENOST Q
    The challenge posed by young-onset rectal cancer.
    Br J Surg. 2020;107:481-483.
    PubMed    
    
    
    
69. TSUKAMOTO S, Fujita S, Ota M, Mizusawa J, et al
    Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Br J Surg. 2020;107:586-594.
    PubMed     Abstract available
    
    
    
70. VAN DER HEIJDEN JAG, Koeter T, Smits LJH, Sietses C, et al
    Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis.
    Br J Surg. 2020;107:489-498.
    PubMed     Abstract available
    
    
    
71. NG KS, Russo R, Gladman MA
    Colonic transit in patients after anterior resection: prospective, comparative study using single-photon emission CT/CT scintigraphy.
    Br J Surg. 2020;107:567-579.
    PubMed     Abstract available
    
    
    
72. ZABOROWSKI AM, Murphy B, Creavin B, Rogers AC, et al
    Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:606-612.
    PubMed     Abstract available
    
    
    
73. AGGER EA, Jorgren FH, Lydrup MA, Buchwald PL, et al
    Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study.
    Br J Surg. 2020;107:580-585.
    PubMed     Abstract available
    
    
    
74. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    PubMed     Abstract available
    
    
    
75. CRIPPA J, Grass F, Achilli P, Mathis KL, et al
    Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:560-566.
    PubMed     Abstract available
    
    
    
76. GRASS F, Hubner M, Mathis KL, Hahnloser D, et al
    Identification of patients eligible for discharge within 48 h of colorectal resection.
    Br J Surg. 2020;107:546-551.
    PubMed     Abstract available
    
    
    
77. KARACHUN A, Panaiotti L, Chernikovskiy I, Achkasov S, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:499-508.
    PubMed     Abstract available
    
    
    
78. SVANSTROM ROJVALL A, Buchli C, Bottai M, Ahlberg M, et al
    Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study.
    Br J Surg. 2020;107:525-536.
    PubMed    
    
    
    March 2020
79. CHAMBERS AC, Dixon SW, White P, Williams AC, et al
    Demographic trends in the incidence of young-onset colorectal cancer: a population-based study.
    Br J Surg. 2020 Mar 9. doi: 10.1002/bjs.11486.
    PubMed     Abstract available
    
    
    
80. RONCATI L, Manenti A, ZIzzo M, Farinetti A, et al
    Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    PubMed    
    
    
    
81. MERKEL S, Hohenberger W
    Author response to: Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    PubMed    
    
    
    February 2020
82. KOBAYASHI M, Kako J, Kajiwara K, Oosono Y, et al
    Comment on: Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2020;107:318.
    PubMed    
    
    
    January 2020
83. ALMAZEEDI S, El-Abd R, Al-Khamis A, Albatineh AN, et al
    Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.
    Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11494.
    PubMed     Abstract available
    
    
    
84. SCHAAP DP, de Valk KS, Deken MM, Meijer RPJ, et al
    Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11523.
    PubMed     Abstract available
    
    
    
85. SARASTE D, Jaras J, Martling A
    Population-based analysis of outcomes with early-age colorectal cancer.
    Br J Surg. 2020 Jan 10. doi: 10.1002/bjs.11333.
    PubMed     Abstract available
    
    
    
86. XU YJ, Sun X, Jiang H, Yin YH, et al
    Randomized clinical trial of continuous transversus abdominis plane block, epidural or patient-controlled analgesia for patients undergoing laparoscopic colorectal cancer surgery.
    Br J Surg. 2020;107:e133-e141.
    PubMed     Abstract available
    
    
    
87. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151-152.
    PubMed    
    
    
    
88. HAJIBANDEH S, Hajibandeh S
    Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151.
    PubMed    
    
    
    
89. WASMUTH HH, Faerden AE, Myklebust TA, Pfeffer F, et al
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:121-130.
    PubMed     Abstract available
    
    
    
90. VAN DER SLUIS FJ, Couwenberg AM, de Bock GH, Intven MPW, et al
    Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.
    Br J Surg. 2020;107:131-139.
    PubMed     Abstract available
    
    
    December 2019
91. LARSEN SG, Pfeffer F, Korner H
    Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    
    
    
    
92. LACY AM, Nogueira ST, de Lacy FB
    Comment on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    
    
    
    November 2019
93. WATT SK, Fransgaard T, Degett TH, Thygesen LC, et al
    Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes.
    Br J Surg. 2019 Nov 22. doi: 10.1002/bjs.11372.
    PubMed     Abstract available
    
    
    October 2019
94. DEN BAKKER CM, Anema JR, Huirne JAF, Twisk J, et al
    Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11313.
    PubMed     Abstract available
    
    
    
95. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    
    
    
    
96. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    
    
    
    August 2019
97. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Abstract available
    
    
    
98. LARSEN SG, Pfeffer F, Korner H
    Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1120-1121.
    PubMed    
    
    
    
99. PUCCIARELLI S, Del Bianco P, Pace U, Bianco F, et al
    Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.
    Br J Surg. 2019;106:1147-1155.
    PubMed     Abstract available
    
    
    
100. ERLANDSSON J, Pettersson D, Glimelius B, Holm T, et al
     Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
     Br J Surg. 2019;106:1248-1256.
     PubMed     Abstract available
     
     
     
101. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
     BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
     Br J Surg. 2019;106:1237-1247.
     PubMed     Abstract available
     
     
     July 2019
102. ROTTIER SJ, van Dijk ST, van Geloven AAW, Schreurs WH, et al
     Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis.
     Br J Surg. 2019;106:988-997.
     PubMed     Abstract available
     
     
     
103. LAKKIS Z, Vernerey D, Mege D, Faucheron JL, et al
     Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
     Br J Surg. 2019;106:1087-1098.
     PubMed     Abstract available
     
     
     
104. ZABOROWSKI A, Stakelum A, Winter DC
     Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.
     Br J Surg. 2019;106:979-987.
     PubMed     Abstract available
     
     
     
105. AMELUNG FJ, Borstlap WAA, Consten ECJ, Veld JV, et al
     Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
     Br J Surg. 2019;106:1075-1086.
     PubMed     Abstract available
     
     
     June 2019
106. BEDNARSKI BK, Nickerson TP, You YN, Messick CA, et al
     Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).
     Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11223.
     PubMed     Abstract available
     
     
     
107. SILLO TO, Beggs AD, Morton DG, Middleton G, et al
     Mechanisms of immunogenicity in colorectal cancer.
     Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11204.
     PubMed     Abstract available
     
     
     
108. HAMID HKS
     Correspondence.
     Br J Surg. 2019;106:949-950.
     PubMed    
     
     
     
109. DUCHALAIS E, Larson DW
     Correspondence.
     Br J Surg. 2019;106:950-951.
     PubMed    
     
     
     
110. 
     Snapshot quiz.
     Br J Surg. 2019;106:836.
     PubMed    
     
     
     
111. QUIRAM BJ, Crippa J, Grass F, Lovely JK, et al
     Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
     Br J Surg. 2019;106:922-929.
     PubMed     Abstract available
     
     
     May 2019
112. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
     Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
     Br J Surg. 2019;106:728.
     PubMed    
     
     
     
113. WESTBERG K, Palmer G, Hjern F, Holm T, et al
     Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
     Br J Surg. 2019;106:790-798.
     PubMed     Abstract available
     
     
     
114. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
     Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
     Br J Surg. 2019;106:783-789.
     PubMed     Abstract available
     
     
     April 2019
115. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
     Meta-analysis of the molecular associations of mucinous colorectal cancer.
     Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
     PubMed     Abstract available
     
     
     
116. KEANE C, Park J, Oberg S, Wedin A, et al
     Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
     Br J Surg. 2019;106:645-652.
     PubMed     Abstract available
     
     
     March 2019
117. ABIS GSA, Stockmann HBAC, Bonjer HJ, van Veenendaal N, et al
     Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
     Br J Surg. 2019;106:355-363.
     PubMed     Abstract available
     
     
     
118. 
     Snapshot quiz.
     Br J Surg. 2019;106:341.
     PubMed    
     
     
     
119. KELLER DS, Reali C, Spinelli A, Penna M, et al
     Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
     Br J Surg. 2019;106:364-366.
     PubMed     Abstract available
     
     
     
120. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
     Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
     Br J Surg. 2019;106:484-490.
     PubMed     Abstract available
     
     
     
121. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
     Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
     Br J Surg. 2019;106:491-498.
     PubMed     Abstract available
     
     
     
122. AHL R, Matthiessen P, Fang X, Cao Y, et al
     Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
     Br J Surg. 2019;106:477-483.
     PubMed     Abstract available
     
     
     February 2019
123. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
     Effect of radiotherapy for rectal cancer on ovarian androgen production.
     Br J Surg. 2019;106:267-275.
     PubMed    
     
     
     January 2019
124. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
     Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
     Br J Surg. 2019;106:132-141.
     PubMed     Abstract available
     
     
     
125. ELFEKI H, Larsen HM, Emmertsen KJ, Christensen P, et al
     Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.
     Br J Surg. 2019;106:142-151.
     PubMed     Abstract available
     
     
     November 2018
126. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
     Sex differences in faecal occult blood test screening for colorectal cancer.
     Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
     PubMed     Abstract available
     
     
     August 2018
127. BARE M, Mora L, Tora N, Gil MJ, et al
     CCR-CARESS score for predicting operative mortality in patients with colorectal cancer.
     Br J Surg. 2018 Aug 13. doi: 10.1002/bjs.10956.
     PubMed     Abstract available
     
     
     
128. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
     Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
     Br J Surg. 2018;105:1210-1220.
     PubMed     Abstract available
     
     
     
129. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
     Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
     Br J Surg. 2018;105:1200-1209.
     PubMed     Abstract available
     
     
     May 2018
130. 
     Advanced colorectal cancer issue.
     Br J Surg. 2018;105:E240-E247.
     PubMed    
     
     
     
131. BROWN KGM, Solomon MJ
     Progress and future direction in the management of advanced colorectal cancer.
     Br J Surg. 2018;105:615-617.
     PubMed    
     
     
     
132. PASSOT G, Dumont F, Goere D, Arvieux C, et al
     Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).
     Br J Surg. 2018;105:663-667.
     PubMed     Abstract available
     
     
     
133. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
     Biomarkers in colorectal liver metastases.
     Br J Surg. 2018;105:618-627.
     PubMed     Abstract available
     
     
     
134. 
     Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
     Br J Surg. 2018;105:650-657.
     PubMed     Abstract available
     
     
     April 2018
135. QUYN AJ, Fraser CG, Rodger J, Digan A, et al
     Participation in bowel screening among men attending abdominal aortic aneurysm screening.
     Br J Surg. 2018;105:529-534.
     PubMed     Abstract available
     
     
     March 2018
136. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
     Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
     Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
     PubMed     Abstract available
     
     
     
137. DUELAND S, Foss A, Solheim JM, Hagness M, et al
     Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
     Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
     PubMed     Abstract available
     
     
     
138. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
     Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
     Br J Surg. 2018;105:447-452.
     PubMed     Abstract available
     
     
     February 2018
139. PARK J, Danielsen AK, Angenete E, Bock D, et al
     Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
     Br J Surg. 2018;105:244-251.
     PubMed     Abstract available
     
     
     
140. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
     Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
     Br J Surg. 2018;105:295-301.
     PubMed     Abstract available
     
     
     January 2018
141. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
     MRI-based score to predict surgical difficulty in patients with rectal cancer.
     Br J Surg. 2018;105:140-146.
     PubMed     Abstract available
     
     
     
142. UBINK I, van Eden WJ, Snaebjornsson P, Kok NFM, et al
     Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
     Br J Surg. 2018;105:e204-e211.
     PubMed     Abstract available
     
     
     
143. MARKS KM, West NP, Morris E, Quirke P, et al
     Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.
     Br J Surg. 2018;105:e99-e109.
     PubMed     Abstract available
     
     
     
144. RYAN EJ, Creagh EM
     Emerging methods in colorectal cancer screening.
     Br J Surg. 2018;105:e16-e18.
     PubMed    
     
     
     
145. GAINES S, Shao C, Hyman N, Alverdy JC, et al
     Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.
     Br J Surg. 2018;105:e131-e141.
     PubMed     Abstract available
     
     
     
146. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
     Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
     Br J Surg. 2018;105:e192-e203.
     PubMed     Abstract available
     
     
     December 2017
147. WESTBERG K, Palmer G, Hjern F, Nordenvall C, et al
     Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
     Br J Surg. 2017;104:1866-1873.
     PubMed     Abstract available
     
     
     November 2017
148. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
     Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
     Br J Surg. 2017;104:1609-1619.
     PubMed     Abstract available
     
     
     
149. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
     Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
     Br J Surg. 2017;104:1640-1647.
     PubMed     Abstract available
     
     
     October 2017
150. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
     Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
     Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
     PubMed     Abstract available
     
     
     
151. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
     Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
     Br J Surg. 2017;104:1462-1469.
     PubMed     Abstract available
     
     
     February 2017
152. MARTLING A, Smedby KE, Birgisson H, Olsson H, et al
     Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
     Br J Surg. 2017;104:278-287.
     PubMed     Abstract available
     
     
     
153. HAIN E, Maggiori L, Manceau G, Mongin C, et al
     Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
     Br J Surg. 2017;104:288-295.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: